Page last updated: 2024-11-12

pyroxasulfone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pyroxasulfone: an herbicide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11556910
CHEMBL ID2251728
SCHEMBL ID117036
MeSH IDM000599101

Synonyms (28)

Synonym
unii-04xp114422
447399-55-5
pyroxasulfone [iso]
pyroxasulfone
04xp114422 ,
isoxazole, 3-(((5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1h-pyrazol-4-yl)methyl)sulfonyl)-4,5-dihydro-5,5-dimethyl-
isoxazole, 3-[[[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1h-pyrazol-4-yl]methyl]sulfonyl]-4,5-dihydro-5,5-dimethyl-
5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)pyrazol-4-ylmethyl 4,5-dihydro-5,5-dimethyl-1,2-oxazol-3-yl sulfone
pyroxasulfone [mi]
3-(((5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1h-pyrazol-4-yl)methyl)sulfonyl)-4,5-dihydro-5,5-dimethylisoxazole
3-({[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1h-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-4,5-dihydroisoxazole
SCHEMBL117036
CHEMBL2251728
DTXSID4058104
3-(((5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1h-pyrazol-4-yl)methyl)sulfonyl)-5,5-dimethyl-4,5-dihydroisoxazole ,
pyroxasulfone 100 microg/ml in acetonitrile
E76681
3-[[[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1h-pyrazol-4-yl]methyl]sulfonyl]-4,5-dihydro-5,5-dimethylisoxazole
c12h14f5n3o4s
3-[[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)pyrazol-4-yl]methylsulfonyl]-5,5-dimethyl-4h-1,2-oxazole
EX-A3526
isoxazole,3-[[[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1h-pyrazol-4-yl]methyl]sulfonyl]-4,5-dihydro-5,5-dimethyl-
isoxazole, 3-[[[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1h-pyrazol-4-yl]methyl]sulfonyl]-4,5-dihydro-5,5-dimethyl-; 3-[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)pyrazol-4-ylmethylsulfonyl]-4,5-dihydro-5,5-dimethyl-1,2-oxazole; kih 485; pyro
Q27247713
BS-53232
3-{[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1h-pyrazol-4-yl]methanesulfonyl}-5,5-dimethyl-4,5-dihydro-1,2-oxazole
EN300-18849515
CS-0132723

Research Excerpts

Overview

Pyroxasulfone (PYR) is a widely used herbicide. Its effects on non-target organisms, particularly microorganisms, are largely unknown.

ExcerptReferenceRelevance
"Pyroxasulfone (PYS) is an isoxazole herbicide favored for its high activity. "( Accumulation and metabolism of pyroxasulfone in tomato seedlings.
Du, N; Liu, X; Ma, C; Niu, Y; Piao, F; Wang, H; Yan, Z; Zhang, JJ; Zhao, T; Zhou, L, 2023
)
2.64
"Pyroxasulfone (PYR) is a widely used herbicide, but its effects on non-target organisms, particularly microorganisms, are largely unknown. "( Impact of pyroxasulfone on sugarcane rhizosphere microbiome and functioning during field degradation.
Bai, L; Cernava, T; Jin, D; Li, W; Ma, Y; Men, J; Wang, Y; Zheng, T, 2023
)
2.76
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (61.54)24.3611
2020's5 (38.46)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 54.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index54.70 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index88.83 (26.88)
Search Engine Supply Index2.13 (0.95)

This Compound (54.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]